Table 2. Baseline characteristic between myCAF high patient and myCAF low patient in PDAC from Shanghai General Hospital and Minhang Hospital.
Clinical features | myCAF-high, mean ± SD | myCAF-low, mean ± SD | P/χ2 |
---|---|---|---|
Age, years | 60.8±9.5 | 61.3±9.0 | P=0.782 |
Size, cm | 3±1.1 | 3.5±1.4 | P=0.112 |
Weight, kg | 64.7±9.4 | 64±10.7 | P=0.78 |
Gender, n | χ2=0.04653 | ||
Male | 19 | 23 | |
Female | 8 | 15 | |
TNM stage, n | χ2=0.069276 | ||
1a | 4 | 3 | |
1b | 8 | 17 | |
2a | 6 | 5 | |
2b | 9 | 14 | |
CA125, U/mL | 29.6±35.6 | 35.5±38.3 | P=0.553 |
CA199, U/mL | 192.2±425.5 | 743.6±3371.9 | P=0.412 |
myCAF, myofibroblast cancer-associated fibroblast; PDAC, pancreatic ductal adenocarcinoma; TNM, tumor node metastasis.